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MYCOTOXINS AND THEIR EFFECT ON HUMAN HEALTH
ABSTRACT: Health risks associated with the consumption of products contaminated 
with mycotoxins are worldwide recognized and depend on the extent to which they are 
consumed in diversified diet. To some extent, the presence of small amount of mycotoxins 
in cereals and related food products is unavoidable; this requires risk assessments which are 
to be carried out by regulatory bodies in several countries to help establish regulatory 
guidelines for the protection of public health. By assessing the levels at which these sub-
stances in food may pose a potential risk to human health, it is possible to devise appropri-
ate risk management strategies. However, several important factors have to be taken into 
account in making a rational risk management decision, such as adequate toxicological data 
and information concerning the extent of exposure, availability of technically sound ana-
lytical procedures (including sampling), socioeconomic factors, food intake patterns and 
levels of mycotoxins in food commodities which may vary considerably between countries.
KEY WORDS: health risk, human health, imunosupression, legislation, mycotoxico-
sis, mycotoxin
INTRODUCTION
From the aspect of human and veterinary medicine, food safety repre-
sents a significant problem. Thus, attention is directed to diseases which are 
closely related to different kinds of mycotoxicoses. Reports from the World 
Health Organization show that the presence of mycotoxins and toxic metabo-
lites of molds in the food for human consumption is not on the decrease. Due 
to the obvious increase in the number of diseases caused by mycotoxins, 
which have been implicated as potential etiological factors, a great effort is 
made to identify mycotoxins present in the food and thereon to eliminate 
them. Besides the already known and studied mycotoxin-related diseases, 
World Health Organization reports also mention other diseases such as Alz-
heimer, multiple sclerosis and cancers.
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A number of studies have documented that mycotoxins are etiological 
factors of a number of respiratory and neurological disorders, as well as can-
cerous changes, nephrotoxicity and hepatotoxicity. Recent studies have shown 
that mycotoxins have a biological role and direct influence on the initiation 
and/or recurrence of nervous system disorders. By repeated stimulation of 
receptors affected by mycotoxins, the relationship between mycotoxicosis and 
Alzheimer’s disease can be explained. This can be used as the study model for 
MCS (Multiple Chemical Sensitivity Syndrome) and other syndromes.
The presence of mycotoxins in food is a problem that mankind, espe-
cially modern society, is faced with, regardless of the fact that there is a big 
difference between developed and underdeveloped parts of the world, primar-
ily in the degree of food contamination with mycotoxins. In underdeveloped 
regions people are constantly exposed to acute or chronic mycotoxicosis. 
However, having due regard to the ongoing struggle for enough food in these 
regions, it would be unrealistic to expect a solution to the problem of myco-
toxicosis. People in developed or highly developed areas of the world are less 
exposed to mycotoxins, primarily due to geographic and climatic conditions. 
In addition, there are considerable food resources, modern processing and 
storage of food is constantly applied, strict legislation is introduced, and there 
is a very strict control of mycotoxins presence in food.
Presence of mycotoxins in animal feedstuff
Contamination with mycotoxins and molds is a world problem. Accord-
ing to FAO data, nowadays 25% of world wheat production is contaminated 
(D e vegowd a  et al., 1998). It is evident that molds and mycotoxins represent 
a serious problem (SCOOP, 1996), not only in regard to successful harvest and 
food quality, but also in the productivity and health of animals (M i l l e r  and 
T r e n h o l m, 1994).
High risk foods
Since there are known limits which designate the contaminated food as 
safe, it is necessary to be able to recognize foods which are the most common 
sources of intoxication (S i n o v e c and R e s a n o v i c, 2005). Such foods on 
organoleptic examination usually appear safe, although mycotoxins are de-
scribed as „cold blooded murderers“. Mycotoxins are most commonly found 
in cereals, coffee, cocoa, nuts, as well as foods of animal origin in which 
mycotoxin residues can be found (milk, meat, offal, eggs).
Milk and milk products. The presence of mycotoxins in milk and dairy 
products is a serious food safety problem, especially for infants and children 
who are most susceptible to mycotoxins, and who are also most exposed to 
this source of poisoning. Mammals, which ingest food contaminated with afla-
toxin, secrete the toxin in their milk in the form of hepatic 4 – hydroxylated 317
metabolite known as “milk toxin”, or aflatoxin M1. AFM1 is slightly less toxic 
than AFB1, therefore, the International Agency for Cancer Research (IARC, 
1993) classified AFM1 as potentially carcinogenic to humans. By taking into 
account the possibility that the OTA and other mycotoxins can be secreted 
into milk, and that the rumen microflora can greatly transform, it can be con-
cluded that the content of mycotoxins in milk poses lower hazard to human 
health.
Powdered milk is another source of AFM1 in the human population, and 
is therefore subject to regulation which is extremely strict concerning this 
product. In the last decade of the twentieth century, AFM1 contamination in 
milk was reduced to a minimum in the EU because there was no legal limit on 
the presence of AFM1 due to the lack of certainty about the effects that very 
low doses of aflatoxin and its body tissue accumulation can have especially 
on children (F r e m y and D r a g a c c i, 1999).
Human milk. Mycotoxins, primarily aflatoxins, represent a serious pre-
natal problem as it is known that some toxins easily pass through the placental 
barrier and can be found in a fetus when a mother consumes contaminated 
food. As mycotoxins (M i r a g l i a et al., 1995) are, as a rule, excreted by 
milk, the highest risk of intoxication in newborns is primarily mother’s milk.
Meat and meat products. Foodstuff, which originates from animals fed 
with contaminated feed, represents a potential hazard to health. Ruminant 
meat represents a slight danger in comparison to pork and poultry due to 
physiological characteristics of the rumen and specific degradation of the ma-
jority of present mycotoxins. 
Aflatoxin is deposited in the tissues and organs of animals which consume 
contaminated feed. Deposition occurs in liver, muscles, stomach, kidneys, 
adipose tissue and meat, the highest deposition of aflatoxin is in the liver (R e -
s a nov ić, 2000).
Ochratoxin is deposited primarily in kidney and liver, as well as in mus-
cle and adipose tissue (J o n k e r and P e t t e r s s o n, 1999). Contamination 
of pork meat with OTA is a major problem, and that is why some European 
countries have introduced special monitoring in slaughterhouses where the pres-
ence of OTA is determined based on post mortem examinations (Mou s si ng 
et al., 1997). 
Zearalenone and its derivatives can be determined in edible portions 
such as liver and muscles of animals fed with contaminated feed (C i e g l e r 
and V e s o n d e r, 1983), as well as in the meat of clinically healthy animals 
(M i l i ć e v i ć et al., 2005).
Relatively rapid metabolic degradation of T-2 toxin is probably the main 
reason for very difficult identification of its presence in meat (P a c e, 1986).
Eggs. The presence of myctoxins in eggs represents a health hazard for 
human population. Aflatoxin B1 residues pose the highest hazard since their 
transformation into AFB1 in the liver of hens causes the formation of a set of 
hydroxylated derivatives which can pass into the egg. Besides the excretion of 
aflatoxin (R a d o v i ć, 1997), there is also a possibility of OTA, ZON and T-2 318
toxin elimination in eggs, mostly in the yolk and to a smaller extent in the egg 
white (F u c h s and H u l t, 1992).
Grains. Given that cereals are the main source of carbohydrates in the 
diet of people around the world, they represent the main source of mycotoxins 
in food. Cereals can easily be infested with fungi in various stages of produc-
tion and storage. A large number of mycotoxins can be found in cereals, and many 
countries have enacted legislation on maximum allowed levels (S m i t h, 1997) 
of mycotoxins in cereals. Corn grain is considered to be the grain most highly 
contaminated with mycotoxins, followed by rice, barley and wheat, oilseeds 
and seeds of peanuts, soybeans and sunflower. The combination of more toxins 
is a pressing problem for the detection of mycotoxins, as well as for the monitor-
ing of the effects that they exert in the body of humans and animals.
Aflatoxin B1 and human health hazard
Humans are most commonly exposed to the effects of aflatoxin in three 
ways:
•  ingestion of food of vegetable origin (mainly corn and peanuts) contami-
nated with aflatoxin (AFB1),
•  Ingestion of contaminated milk and dairy products, including cheese and 
powdered milk (AFM1) and,
•  Ingestion of aflatoxin residues present in meat and meat products, as well 
as in eggs (to a lower degree than in the previous two ways).
A number of health disorders are developed as a result of aflatoxin inges-
tion; they differ based on the degree, character and intensity relative to the 
quantity of ingested aflatoxin, length of exposure, general health status and 
age of the patient.
Hepatocellular carcinoma is one of the most common malignant diseases, 
and it is the fourth most common cause of death. Early epidemiological studies 
indicated to the close relationship between hepatocellular carcinoma and ex-
posure to aflatoxin B1, i.e. exposure to contaminated food. The incidence of 
primary hepatocellular carcinoma increases logarithmically with an increase 
in aflatoxin ingestion which was proven by further studies. In geographic re-
gions where hepatocellular carcinoma is rare, AFB1 contamination in food is 
very low.
Aflatoxins, particularly AFB1, show an emphasized carcinogenic effect 
(E a t o n and G r o o p m a n, 1994). The International Agency for Research 
on Cancer (IARC, 1993) classified the AFB1 in the group 1 carcinogens, since 
the risk of human primary liver cancer is very high (H e n r y et al., 2001).
Acute toxic hepatitis is a disease which has been described in many geo-
graphic regions, but the highest prevalence was recorded in India. The examina-
tion performed on 674 patients in 150 cities of India showed that all patients 
consumed moldy corn, and that aflatoxin B1 was present in most samples in 
quantities of 0.25-15.6 mg / kg. Considering the fact that adults eat at least 400 g 
of corn daily on the territory where the survey was conducted, it can be con-319
cluded that exposure to aflatoxin was above 6 mg / day. Histopathological 
examination of the liver of patients who died of acute toxic hepatitis revealed 
bile duct proliferation accompanied by periductal fibrosis and cholestasis. 
Aflatoxin was also detected in the tested urine of affected patients. 
Kwashiorkor is a protein deficiency which manifests as hypoalbumine-
mia, generalized edema, dermatosis, enlarged fatty liver, and it is common in 
geographic regions where seasonal occurrence of aflatoxin is present. Afla-
toxin was recorded in liver samples of 36 children who deceased due to 
Kwashiorkor (H e n d r i c k s e, 1985). This implies that aflatoxin is one of the 
possible etiological factors along with the possibility that malnutrition alters 
aflatoxin metabolism (D e V r i e s, 1989).
Reye’s syndrome is a form of hepatic encephalopathy in children accom-
panied by fatty degeneration of parenchymal organs. Although Reye’s syn-
drome occurs in many countries around the world and geographical link with 
the areas with a high risk of aflatoxin ingestion has not been observed, afla-
toxin is considered as one of the etiological factors. The first hypothesis of a 
causal connection dates back in 1963 when the presence of aflatoxin B1 and 
G2 in the serum of patients suffering and dying from Reye’s syndrome was 
recorded. Also, AFB1 was detected in the liver of 27 patients suffering from 
Reye’s syndrome, while AFM1 was detected in only 4 patients (B r y d e n, 
2007). Taking into account the research carried out in conjunction with Reye’s 
syndrome, it was concluded that the disease etiology was multifactorial, and 
aflatoxin played an important role in the pathogenesis.
T4 lymphocyte deficiency may be caused by the presence of aflatoxins in 
human food because it is known that aflatoxins are mitogenic factors for T4 
lymphocytes and cause symptoms related to deficiency of T4 lymphocytes 
(G r i f f it sh  et al., 1996).
There are exact data on the dietary intake of aflatoxins, but they are 
based only on available data and different models for certain given values. 
Average daily intake of aflatoxin B1 ranged from 2-77 ng / man or 0.4-0.6 ng 
AFM1/man (SCOOP, 1996).
Ochratoxin A and human health hazard
It has been believed for a long time that ochratoxin is responsible for 
nephropathies and urinary tract tumors in man. High exposures to OTA, high 
concentration in blood serum and long half-life (35 days), as well as the depo-
sition in the kidneys foster the development of nephrotoxicity.
OTS is significant for its relationship with Balkan Endemic Nephropathy 
(BEN) which is a chronic kidney disorder (Krogh et al., 1977) with lethal 
outcome (R a d o v a n o v i ć, 1991). BEN has an endemic character and it was 
recorded in rural regions of the Balkans (parts of Bosnia and Herzegovinia, 
Croatia, Serbia, Romania, and Bulgaria) and it is more common in woman 
than in man. Kidneys are smaller, tubules are degenerated, and interstitial fi-320
brosis and glomerule hyalinisation are present in the cortex. Tubular function 
is decreased and this is one of the first clinical signs. 
High levels of OTA and β-2 microglobulins in the serum characterize 
chronic interstitial nephropathy. Previously performed studies (R a d i ć et al., 
1986) confirmed that 56.6% of tested sera from patients with nephropathy 
from the Western Posavina region were positive for ochratoxin A. Data from 
Vraca (Bulgaria), where entire families were affected with BEN, showed high 
concentrations of OTA in the sera samples from patients. In some North Af-
rican countries, especially Tunisia, epidemiological studies show a high rela-
tionship between OTA and chronic interstitial nephropathy.
On the other hand, there are contradictory data which state that there is no 
connection between BEN and high OTA concentrations in serum (G ros so 
et al., 2003; Abid et al., 2003). Therefore, the question on the relationship be-
tween OTA and BEN still remains unanswered. Difficulties arise due to the 
seasonal presence of OTA in food, allowed limits for OTA in serum and food, 
qualitative and quantitative laboratory procedures for OTA determination, 
and still incomplete knowledge about synergistic effects of different mycotox-
ins. In fact, citrinin stimulates the effects of OTA and citrinin concentrations 
in the food samples from Vrac were 200 times higher than OTA concentra-
tions.
With high content of OTA in food (C i e g l e r and V e s o n d e r, 1983), 
there was a high incidence of renal adenomas and carcinomas (R a dova   no -
v ic  et al., 1991), and there is a correlation between the occurrence of BEN 
and urinary tract tumors. The importance of OTA induced renal carcinomas 
is increased due to frequent metastases in the lymph nodes and liver in hu-
mans, and multiplication of the mammary gland – fibroadenoma in women. 
This is why the International Agency for Research on Cancer (IARC, 1993) 
classified OTA as carcinogenic potential for human population (group B).
The exact data on the dietary intake of ochratoxin do not exist, and most 
of the information is obtained from Europe where, unlike other regions of the 
world, OTA is a common food contaminant. Average daily intake of OTA was 
estimated to be 45 mg / kg bw / week, out of which 25 ng was from grains, 10 
ng from wine and meat and only 1.5 ng from pork (WHO, 1985). According 
to the other data and model calculations, it was believed that the daily intake 
of OTA was up to 92 mg / kg bw / week in countries where the consumption 
of grains was significant. Data from countries that had a very low incidence 
of nephropathy showed that daily intake of OTA ranged 1-5 mg / kg bw / day 
(SCOOP, 1997).
Zearalenone and human health hazards
Due to its estrogenic structure, it is considered that zearalenone and/or 
its derivatives, especially zearalanol, cause precocious puberty in children at 
the age of 7-8 (P a i n t e r, 1977). Epidemiological study performed in Por-
torico (S a e n z d e R o d r i g u e z et al., 1985) showed that areas where 321
children suffer from praecox puberty are characterized with high concentra-
tion of estradiol and its equivalent in meat, and zearalenone and its metabo-
lites were recorded in the blood plasma of affected children. It is believed that 
exposure to zeralenone occurred during pregnancy of their mothers who con-
sumed contaminated food at the time of pregnancy. A similar phenomenon was 
investigated in the southeastern region of Hungary, and zearalenone concentra-
tion in the blood of patients with precocious puberty ranged from 18.9-103.5 
mg / ml.
F-2 toxin can cause oestrogenisation and pseudopregnancy in women 
and, inhibition of the normal development of testicles in men. It is also associ-
ated with the development of prostate cancer in men, and there is a hypothesis 
that zearalenone can be an etiological factor not only for premature puberty but 
for cervical cancer as well (H sieh, 1989). However, the International Agen-
cy for Research on Cancer (IARC, 1993) believes that there has not been data 
reliable enough to classify F-2 toxin as potential carcinogen in the population 
of people (group 3). On the other hand, the use of derivatives of zearalenone 
was used to relieve the symptoms of menopausal disorders.
The exact data on the dietary intake of zearalenone do not exist, except 
for Canada and Northern Europe. Average daily intake of F-2 toxin was estimated 
to be from 0.03 to 00:06 mg / kg bw / day (WHO, 1985), and 1.2-1.5 ng / day, 
or 0:01 to 00:02 mg / kg bw / day (E r i k s e n and A l e x a n d e r, 1998). The 
determined values were below PTDI of 0.2 mg / kg bw / day. However, the 
assumption is that the mean intake of zearalenone in Europe ranges from 
1-420 ng / kg body weight (EC, 2003).
T-2 toxin and human health hazard
Trichothecene toxicity mechanisms reside on strong inhibition of protein 
synthesis, and this results in a set of negative effects to human health.
Alimentary toxic aleukia (ATA) is a disorder characterized by necrotic 
angina, hemorrhagic diathesis and sepsis accompanied by granulocitosis as a 
result of bone marrow atrophy. The disease had fatal consequences in 80% of 
cases (J o f f e, 1978). The disease is caused by the ingestion of cereals con-
taminated with molds of the Fusarium genus (F. poae and F. sporotrichoides). 
Nowadays, ATA is considered to be largely eradicated disease since 
there is a high exposure of large number of people to trichothecene mycotox-
ins. In addition, the International Agency for Research on Cancer (IARC, 
1993) classified T-2 toxin as carcinogenic potential for the population of peo-
ple (group 3).
In addition to ATA, diseases related to ingestion of food contaminated 
with Fusarium molds and / or T-2 toxin (C a n a d y  et al., 2001) appeared spo-
radically in the second half of the twentieth century, mainly in Asia (Japan, 
Korea, China and India, Kashmir). The disease occurs shortly (5-30 min, max 
1 hour) after the ingestion of contaminated food (0.2-0.8 mg T-2/kg) mainly 
wheat, and it is followed by nausea and abdominal pain (100%), irritation of 322
the mouth and larynx (63%), diarrhea (39%), melena (5%), vomiting (7%). Un-
like ATA, none of the diseases had fatal consequences.
Based on the results of analysis performed on food for humans, the aver-
age daily intake of T-2 toxin was estimated to be 7.6 ng / kg bw (WHO, 1985). 
In any respect, more detailed studies need to be performed in different regions 
of the world, especially in European countries in order to obtain more accu-
rate information about the overall intake of this toxin in humans. 
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Резиме
Здравствени ризици повезани са конзумацијом производа контаминираних 
микотоксинима су препознати у целом свету. У извесној мери присуство малих 
количина микотоксина у житарицама и другим производима је очекивано и  неми-
новно. То изискује процену ризика од стране регулаторних тела која морају имати 
улогу у успостављању регулаторних смерница за заштиту јавног здравља. Након 
процене нивоа микотоксина у храни потребно је осмислити одговарајуће страте-
гије за управљање ризиком. Неколико важних фактора треба узети у обзир при 
доношењу одлука о рационалном управљању ризиком, укључујући токсиколошке 
податке, нивое изложености, доступност аналитичких процедура, социоеконом-
ске факторе и националну легислативу.
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конска регулатива, здравље људи